Adil Mohyudin
Internal Medicine · Jackson, MSNPI 1851913172
Payments from drug & device makers
What this record shows
This record is dominated by food and beverage: $1,632 of the $1,822 with a category attached, or 89.6%. It is spread thinly across 30 manufacturers, the largest accounting for just 16.2% — the pattern of someone who eats at a lot of different presentations.
Across 71 payments — averaging $25.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$295
- Takeda Pharmaceuticals U.S.A., Inc.$185
- Incyte Corporation$173
- Bristol Myers Squibb$154
- Novartis$146
- AstraZeneca$117
- plus $751 from 24 others
What the payments were for
- Food & beverage$1,63290%
- Education$19010%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson(2 entities) | 6 | $295 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $185 |
| Incyte Corporation | 5 | $173 |
| Bristol Myers Squibb | 7 | $154 |
| Novartis | 9 | $146 |
| AstraZeneca(2 entities) | 3 | $117 |
| AbbVie | 5 | $104 |
| Rigel Pharmaceuticals, Inc. | 3 | $69 |
| Merck | 3 | $54 |
| Pfizer | 2 | $43 |
| Astellas Pharma US Inc | 2 | $38 |
| Emmaus Medical, Inc. | 2 | $38 |
| GSK | 2 | $34 |
| Immunocore Limited | 1 | $33 |
| Sanofi | 2 | $33 |
| Sanofi-aventis U.S. LLC | 1 | $27 |
| AVEO Pharmaceuticals, Inc. | 1 | $26 |
| Pharmaessentia USA Corporation | 1 | $25 |
| Stemline Therapeutics Inc. | 1 | $24 |
| Novo Nordisk | 1 | $23 |
| ADC Therapeutics America, Inc. | 1 | $22 |
| Jazz Pharmaceuticals Inc. | 1 | $21 |
| Regeneron Healthcare Solutions, Inc. | 1 | $20 |
| Taiho Oncology, Inc. | 1 | $20 |
| Sobi, Inc | 1 | $19 |
| Gilead | 1 | $18 |
| Array Biopharma Inc | 1 | $17 |
| Boehringer Ingelheim | 1 | $15 |
| E.r. Squibb & Sons, L.L.C. | 1 | $14 |
| Seagen Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$1,822 in reported general payments places this provider in the 70th percentile of 846 internal medicine providers in Mississippi.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Pantoprazole Sodium | 12 | $124 |
| Carvedilol | 11 | $93 |
Paid to pharmacies, not to this prescriber.
Other internal medicine in Jackson
- Kelly WilkinsonJackson$79K
- Shanna PettieJackson$53K
- Gabriel HernandezJackson$41K
- Brendan RossJackson$19K
- Hassan CheemaJackson$16K
- James WilliamsJackson$15K
- Day LennepJackson$13K
- Carrie WynnJackson$12K
- Yanglin GuoJackson$10K
- Benedict EwaleifohJackson$9K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.